ANIP
ANI PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$76.14
+0.99%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- $2.12
- Revenue estimate
- $280.1M
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- $2.21
- EPS estimate
- $2.04
- Revenue actual
- $266.0M
- Revenue estimate
- $260.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +29.0%
- Revenue beats (12Q)
- 10
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $105
- PT range
- $90 – $119
- Analysts
- 2
1 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | $2.04 | $2.21 | Beat 8.33% | $266.0M |
| May 8, 2026 | $1.28 | $2.05 | Beat 60.16% | $237.5M |
| Nov 7, 2025 | $1.74 | $2.04 | Beat 17.24% | $227.8M |
| Aug 8, 2025 | $1.38 | $1.80 | Beat 30.43% | $211.4M |
| May 9, 2025 | $1.37 | $1.70 | Beat 24.09% | $197.1M |
| Feb 28, 2025 | $1.41 | $1.63 | Beat 15.60% | $190.6M |
| Nov 8, 2024 | $1.09 | $1.34 | Beat 22.94% | $148.3M |
| May 10, 2024 | $0.98 | $1.21 | Beat 23.47% | $137.4M |
| Feb 29, 2024 | $0.80 | $1.00 | Beat 25.00% | $131.7M |
| Mar 9, 2023 | $0.68 | $0.76 | Beat 11.76% | $94.2M |
| Mar 15, 2022 | $0.82 | $0.54 | Miss -33.99% | $60.9M |
| Nov 1, 2021 | $0.71 | $1.01 | Beat 41.65% | $52.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026